Literature DB >> 9059887

Human NK cells: their ligands, receptors and functions.

H Reyburn1, O Mandelboim, M Valés-Goméz, E G Sheu, L Pazmany, D M Davis, J L Strominger.   

Abstract

The expression, or lack thereof, of class I MHC glycoproteins has a marked influence on natural killer cell function. Cells which do not express class I MHC molecules are susceptible to lysis by NK cells, and transfection of these targets with class I MHC genes can render these cells resistant to NK attack. This inhibition of NK-killing is mediated by a novel family of receptors expressed mainly on NK cells, but also found on some T-cells. The function of these class I MHC binding receptors when expressed on T-cells is discussed also and a novel co-stimulatory activity of NKAR described. Lastly, a novel mechanism by which human cytomegalovirus evades immune surveillance by NK cells is documented.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059887     DOI: 10.1111/j.1600-065x.1997.tb00944.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

1.  In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.

Authors:  Ella Rosenne; Liat Sorski; Lee Shaashua; Elad Neeman; Pini Matzner; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2013-12-12       Impact factor: 7.217

2.  UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.

Authors:  Yoshie Iizuka; Frank Cichocki; Andrew Sieben; Fabio Sforza; Razaul Karim; Kathleen Coughlin; Rachel Isaksson Vogel; Riccardo Gavioli; Valarie McCullar; Todd Lenvik; Michael Lee; Jeffrey Miller; Martina Bazzaro
Journal:  J Immunol       Date:  2015-10-05       Impact factor: 5.422

3.  Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.

Authors:  A Porgador; O Mandelboim; N P Restifo; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Immunological mechanism of the low-dose radiation-induced suppression of cancer metastases in a mouse model.

Authors:  Ewa M Nowosielska; Aneta Cheda; Jolanta Wrembel-Wargocka; Marek K Janiak
Journal:  Dose Response       Date:  2009-12-10       Impact factor: 2.658

5.  HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer.

Authors:  Maureen P Martin; Ingrid B Borecki; Zhengyan Zhang; Loan Nguyen; Duanduan Ma; Xiaojiang Gao; Ying Qi; Mary Carrington; Janet S Rader
Journal:  Immunogenetics       Date:  2010-09-21       Impact factor: 2.846

6.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

Authors:  P Paul; N Rouas-Freiss; I Khalil-Daher; P Moreau; B Riteau; F A Le Gal; M F Avril; J Dausset; J G Guillet; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 8.  The contribution of gammadelta T cells to the pathogenesis of EAE and MS.

Authors:  Sarah E Blink; Stephen D Miller
Journal:  Curr Mol Med       Date:  2009-02       Impact factor: 2.222

Review 9.  What goes up must come down: the emerging spectrum of inhibitory receptors.

Authors:  W M Yokoyama
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

10.  The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis.

Authors:  C S Chang; L Brossay; M Kronenberg; K P Kane
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.